Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Clinical Decision Support System Market size was valued at USD 2.26 Billion in 2024 and is poised to grow from USD 2.43 Billion in 2025 to USD 4.41 Billion by 2033, growing at a CAGR of 7.7% during the forecast period (2026–2033).

    The market is indeed not overly highly competitive. The market has been distinguished by the presence of prominent participants as well as other clinical decision support system suppliers. To gain a competitive advantage over one another, these players engage in new product launches, product innovations, acquisitions, and partnerships. 'Epic Systems Corporation (United States)', 'Oracle (United States) ', 'Athenahealth (United States) ', 'Elsevier (division of RELX Group) (Netherlands) ', 'Koninklijke Philips N.V. (Netherlands) ', 'Medical Information Technology, Inc. (MEDITECH) (United States) ', 'CureMD Healthcare (United States) ', 'EBSCO Information Services (United States) ', 'GE Healthcare (United States) ', 'eClinicalWorks, LLC (United States) ', 'The Medical Algorithms Company Limited (United Kingdom) ', 'Hera-MI (France) ', 'RampMedical (Germany) ', 'VisualDx (United States) ', 'First Databank, Inc. (FDB) (United States) ', 'Strata Decision Technology (United States) ', 'Alcidion (Australia)'

    The European Union's health ministers agreed to work together and create an eHealth common area in 2021, allowing for the free flow of electronic health records throughout the continent. The declaration also urges the inclusion of eHealth as a key component of the Europe 2021 strategy. Such policies/initiatives are expected to increase the demand for and uptake of EHR, which will have an impact on the uptake of CDSS in important global markets.

    The growth of partnerships between CDSS providers and hospitals has significantly increased during the last few years. The demand is expected to rise even more as a result of government recognition and activities to promote the deployment of CDSS and EHR systems. By lowering the amount of time spent looking up a patient's medical history and records, integration with electronic health records (EHR) increases the effectiveness of clinical care. Additionally, the Health and Medicare Acts of the United States Government have approved CDSS, financially rewarding CDS integration into EHRs (Electronic Health Records). A CDSS was present in approximately 41% of American hospitals with an EHR in 2021, and a cutting-edge CDS was available in 40.2% of American hospitals in 2021. Additionally, businesses collaborate to create and offer software that is updated with the most recent data.

    A large portion of the global market for clinical decision support systems is expected to be dominated by North America due to the region's higher adoption of clinical decision systems by healthcare organisations. In addition, the introduction of new technologies to integrate existing data handling systems, such as EHR and clinical decision systems, are providing patients with predictive scenarios, which are responsible for better patient experience and treatment.

    Feedback From Our Clients

    Global Clinical Decision Support System Market

    Report ID: SQSG45F2024

    $5,300
    BUY NOW